Recent EBS Stock Price | EBS Stock Predictions | |
$2.29 | +118.34% |
$5.00 |
Recent EBS Analyst Ratings Breakdown, Making EBS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 0 | 0 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 1 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 3.0 | 3.0 | 4.0 | 3.67 |
For the EBS stock predictions from the analysts covering Emergent BioSolutions Inc, we have collected all of the individual EBS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering EBS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since EBS stock predictions may vary widely, another useful metric to consider is the median EBS stock prediction, which represents the price at which half of the analysts
made EBS stock predictions that were higher and half made EBS stock predictions that were lower. This makes for a different take on the EBS stock predictions out there, as compared to average or mean.
And that median across all the individual EBS stock predictions was: $5.0 as of 2024-04-24.
The very highest of the EBS stock predictions for one year price target was $5.0, while the very lowest of the EBS stock predictions in the analyst group was
$5.0 (with a standard deviation of $0.0). Get the latest Zacks research report on EBS — FREE
Find out: EBS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
AFL Stock Predictions
OBSV Stock Predictions
TENB Stock Predictions
HESM Stock Predictions
DHI Stock Predictions
CULP Stock Predictions
PROV Stock Predictions
TBIO Stock Predictions
UL Stock Predictions
|
|
Hold (2.00 out of 4) 0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |